论文部分内容阅读
目的探讨脂肪肝中应用硫普罗宁注射剂联合HD-91-Ⅱ型肝病治疗仪的临床效果。方法 380例脂肪肝患者,随机分为治疗组(189例)与对照组(191例),治疗组采用硫普罗宁注射剂0.2g静脉滴注,肝病治疗仪经络穴位加中药局部透入,1次/d。对照组不用肝病治疗仪治疗,硫普罗宁注射剂用量用法同治疗组。其他综合治疗方法两组均相同。疗程28 d。观察并比较两组患者临床症状、谷丙转氨酶、谷草转氨酶、转肽酶、甘油三酯胆固醇及彩色多普勒肝脏图像的变化。结果治疗组总有效率100.00%,对照组总有效率55.5%,治疗组总有效率高于对照组(P<0.05)。治疗组各项治疗指标均明显优于对照组(P<0.05)。结论硫普罗宁注射剂与HD-91-Ⅱ肝病治疗仪联合治疗脂肪肝,效果显著,值得临床推广应用。
Objective To investigate the clinical effect of using tiopronin injection combined with HD-91-Ⅱ liver disease therapeutic device in fatty liver. Methods A total of 380 patients with fatty liver were randomly divided into treatment group (n = 189) and control group (n = 191). The treatment group received intravenous injection of tiopronin 0.2g, liver meridian acupoint plus traditional Chinese medicine, / d. The control group without treatment of liver disease treatment, the amount of tiopronin injection with the treatment group. Other methods of treatment are the same for both groups. Treatment 28 d. The changes of clinical symptoms, alanine aminotransferase, aspartate aminotransferase, transpeptidase, triglyceride cholesterol and color Doppler liver in the two groups were observed and compared. Results The total effective rate was 100.00% in the treatment group and 55.5% in the control group. The total effective rate in the treatment group was higher than that in the control group (P <0.05). The treatment group of treatment indicators were significantly better than the control group (P <0.05). Conclusion The combination of tiopronin injection and HD-91-Ⅱ liver disease treatment device has a significant effect on fatty liver and is worthy of clinical application.